End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17,400 KRW | -1.97% | -7.79% | -15.74% |
Mar. 08 | Daewoong Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 15 | Daewoong Pharmaceutical Secures Approval for Stem Cell Processing Facility in Indonesia | MT |
Sales 2024 * | 1,883B 1.37B | Sales 2025 * | 2,082B 1.52B | Capitalization | 711B 518M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.48 x |
Net Debt 2024 * | 199B 145M | Net Debt 2025 * | 112B 81.83M | EV / Sales 2025 * | 0.4 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 348 |
Yield 2024 * |
0.57% | Yield 2025 * |
0.57% | Free-Float | 31.92% |
1 day | -1.97% | ||
1 week | -7.79% | ||
Current month | -13.86% | ||
1 month | -10.54% | ||
3 months | -12.83% | ||
6 months | +6.49% | ||
Current year | -15.74% |
Managers | Title | Age | Since |
---|---|---|---|
Jae-Chun Yoon
CEO | Chief Executive Officer | 64 | 85-07-31 |
Chang-Jae Lee
BRD | Director/Board Member | 47 | 02-11-30 |
Woo-Bang Jeon
AUD | Comptroller/Controller/Auditor | 62 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Young-Cheol Kang
BRD | Director/Board Member | 67 | 22-03-28 |
Jae-Chun Yoon
CEO | Chief Executive Officer | 64 | 85-07-31 |
Geon-Haeng Lee
BRD | Director/Board Member | 63 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 4 M€ | -4.41% | - | |
0.00% | 117 M€ | -1.49% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 17,400 | -1.97% | 39,840 |
24-04-16 | 17,750 | -3.01% | 59,075 |
24-04-15 | 18,300 | -0.54% | 37,088 |
24-04-12 | 18,400 | -1.23% | 31,319 |
24-04-11 | 18,630 | -1.27% | 75,412 |
End-of-day quote Korea S.E., April 16, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.74% | 514M | |
+20.29% | 44.1B | |
+17.11% | 21.97B | |
+8.36% | 13.27B | |
+7.10% | 13.22B | |
+36.34% | 11.36B | |
-8.53% | 7.07B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.09% | 5.23B |
- Stock Market
- Equities
- A003090 Stock